Artelo Biosciences, Inc.
Artelo Biosciences, Inc. (ARTLW) Stock Overview
Explore Artelo Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
13.1K
P/E Ratio
-1.41
EPS (TTM)
$-1.43
ROE
19.37%
ARTLW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Artelo Biosciences, Inc. (ARTLW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.41 and a market capitalization of 13.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.